BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35727670)

  • 21. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications.
    Gottfried ON; Viskochil DH; Fults DW; Couldwell WT
    Neurosurgery; 2006 Jan; 58(1):1-16; discussion 1-16. PubMed ID: 16385324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings.
    Spurlock G; Knight SJ; Thomas N; Kiehl TR; Guha A; Upadhyaya M
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1869-80. PubMed ID: 20229272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biallelic somatic inactivation of the NF1 gene through chromosomal translocations in a sporadic neurofibroma.
    Storlazzi CT; Von Steyern FV; Domanski HA; Mandahl N; Mertens F
    Int J Cancer; 2005 Dec; 117(6):1055-7. PubMed ID: 15986446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurofibromas in NF1: Schwann cell origin and role of tumor environment.
    Zhu Y; Ghosh P; Charnay P; Burns DK; Parada LF
    Science; 2002 May; 296(5569):920-2. PubMed ID: 11988578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenic and invasive properties of neurofibroma Schwann cells.
    Sheela S; Riccardi VM; Ratner N
    J Cell Biol; 1990 Aug; 111(2):645-53. PubMed ID: 1696266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term culture and characterization of human neurofibroma-derived Schwann cells.
    Rosenbaum T; Rosenbaum C; Winner U; Müller HW; Lenard HG; Hanemann CO
    J Neurosci Res; 2000 Sep; 61(5):524-32. PubMed ID: 10956422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of nerve microenvironment for neurofibroma development.
    Liao CP; Pradhan S; Chen Z; Patel AJ; Booker RC; Le LQ
    Oncotarget; 2016 Sep; 7(38):61500-61508. PubMed ID: 27517146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
    Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
    Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoamide Inhibits NF1 Deficiency-induced Epithelial-Mesenchymal Transition in Murine Schwann Cells.
    Zhang Y; Zhou R; Qu Y; Shu M; Guo S; Bai Z
    Arch Med Res; 2017 Aug; 48(6):498-505. PubMed ID: 29198560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do non-pathogenic variants of DNA mismatch repair genes modify neurofibroma load in neurofibromatosis type 1?
    Harder A
    Childs Nerv Syst; 2022 Apr; 38(4):705-713. PubMed ID: 34997843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
    Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
    Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific expression of the neurofibromatosis type 1 gene (NF1) in the hamster Schwann cell.
    Nakamura T; Nemoto T; Arai M; Yamazaki Y; Kasuga T; Gutmann DH; Collins FS; Ishikawa T
    Am J Pathol; 1994 Mar; 144(3):549-55. PubMed ID: 8129040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatiotemporal Loss of
    Chen Z; Mo J; Brosseau JP; Shipman T; Wang Y; Liao CP; Cooper JM; Allaway RJ; Gosline SJC; Guinney J; Carroll TJ; Le LQ
    Cancer Discov; 2019 Jan; 9(1):114-129. PubMed ID: 30348677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mast cells and the neurofibroma microenvironment.
    Staser K; Yang FC; Clapp DW
    Blood; 2010 Jul; 116(2):157-64. PubMed ID: 20233971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unilateral gingival enlargement in patient with neurofibromatosis type I.
    Asgary S; Aminzadeh N
    N Y State Dent J; 2012 Nov; 78(6):50-3. PubMed ID: 23488326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells.
    Li H; Zhang X; Fishbein L; Kweh F; Campbell-Thompson M; Perrin GQ; Muir D; Wallace M
    Cancer Biol Ther; 2010 Oct; 10(8):758-64. PubMed ID: 20699653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.
    Thomas L; Kluwe L; Chuzhanova N; Mautner V; Upadhyaya M
    Neurogenetics; 2010 Oct; 11(4):391-400. PubMed ID: 20358387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synchronous Upper Intestinal Neurofibromas and Duodenal Periampullary Well-Differentiated Neuroendocrine Tumor Associated With Neurofibromatosis 1.
    Balmer JC; Mikhaylov Y; Lewin DN; Mahvi DM; Ramsay Camp E
    Am Surg; 2021 Jan; 87(1):128-130. PubMed ID: 32856931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric carcinoid: germline and somatic mutation of the neurofibromatosis type 1 gene.
    Stewart W; Traynor JP; Cooke A; Griffiths S; Onen NF; Balsitis M; Shah AA; Upadhyaya M; Tobias ES
    Fam Cancer; 2007; 6(1):147-52. PubMed ID: 16944271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.
    Yang FC; Ingram DA; Chen S; Zhu Y; Yuan J; Li X; Yang X; Knowles S; Horn W; Li Y; Zhang S; Yang Y; Vakili ST; Yu M; Burns D; Robertson K; Hutchins G; Parada LF; Clapp DW
    Cell; 2008 Oct; 135(3):437-48. PubMed ID: 18984156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.